Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Retinal Morpho-functional Evaluation of Patients Affected by Inherited Retinal Dystrophies (NEU 02-25)

11. november 2026 oppdatert av: Fondazione G.B. Bietti, IRCCS

The present study aims to perform a detailed morpho-anatomical and electro-functional characterization of patients affected by IRD, to investigate on the features of specific retinal layers (outer and inner) and to identify the functional involvement of macular elements located in specific areas. Through a systematic approach to anatomical and functional pattern classifications, this study seeks to refine the phenotypic understanding of IRD and to contribute to a deeper comprehension of its pathophysiological underpinnings, for exploring whether subretinal factors are involving in the etiopathogenesis.

Studieoversikt

Status

Rekruttering

Forhold

Detaljert beskrivelse

This single-center retrospective observational study evaluates retinal structure and function in patients with clinically confirmed inherited retinal dystrophies. Patients are identified consecutively from those evaluated between 2015 and August 31, 2025. After written informed consent is obtained, demographic and clinical data are extracted from existing records, together with results from a single previously completed ophthalmic visit (Visit 1). The data include medical history, best-corrected visual acuity, anterior and posterior segment examination, intraocular pressure, spectral-domain optical coherence tomography, optical coherence tomography angiography, multifocal electroretinography, multifocal photopic negative response recordings, visual field testing, and documented ocular complications related to inherited retinal dystrophies.

Studietype

Observasjonsmessig

Registrering (Antatt)

18

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 90 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Patients aged 18 to 90 years with clinically confirmed inherited retinal dystrophies who were evaluated at the study center between 2015 and August 31, 2025, and have the clinical and instrumental records required by the protocol.

Beskrivelse

Inclusion Criteria:

  • Patients with clinically confirmed inherited retinal dystrophy
  • Age between 18 and 90 years
  • Male or female patients
  • Available recordings of mfERG and mfPhNR, SD-OCT and OCT-A, Visual Acuity (BCVA) and Visual Field (VF)
  • Phakic and pseudophakic eyes
  • Informed consent freely granted and acquired before data collection

Exclusion Criteria:

  • Patients underwent cataract surgery 6 months before data acquisition
  • Patients with any other ophthalmological diseases affecting cornea, lens, optic nerve and acquired retinal diseases (i.e. central serous chorioretinopathy, retinal vein occlusion, age-related macular degeneration) at the time of data acquisition
  • Patients with diabetes and\or any other systemic condition affecting the macular function and structure
  • Patients who underwent to macular laser procedures before data acquisition
  • Concomitant treatment with any systemic or ocular drug influencing macular structure and function at the time of data acquisition

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: RETROSPECTIVE

Kohorter og intervensjoner

Gruppe / Kohort
Patients with inherited retinal dystrophies

Patients with clinically confirmed inherited retinal dystrophies identified consecutively from those evaluated at the study center between 2015 and August 31, 2025

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Central Retinal Thickness Measured by SD-OCT
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Central retinal thickness, in micrometers (µm), measured by spectral-domain optical coherence tomography (SD-OCT).

At a single previously completed ophthalmic visit (Visit 1).
Ring 1 Response Amplitude Density Measured by Multifocal Electroretinography
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Response amplitude density, in nV/deg², measured by multifocal electroretinography (mfERG) in the innermost fovea-centered ring (R1).

At a single previously completed ophthalmic visit (Visit 1).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Best-Corrected Visual Acuity
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Mean best-corrected visual acuity, expressed in logMAR.

At a single previously completed ophthalmic visit (Visit 1).
Multifocal Electroretinography Response Amplitude Density by Macular Ring
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Response amplitude density, in nV/deg², measured by multifocal electroretinography (mfERG) and reported separately for the five fovea-centered rings (R1-R5).

At a single previously completed ophthalmic visit (Visit 1).
Multifocal Photopic Negative Response Amplitude Density by Macular Ring
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Response amplitude density, in nV/deg², measured from multifocal photopic negative response (mfPhNR) recordings and reported separately for the five fovea-centered rings (R1-R5).

At a single previously completed ophthalmic visit (Visit 1).
Mean Perimetric Sensitivity
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Mean perimetric sensitivity derived from visual field testing.

At a single previously completed ophthalmic visit (Visit 1).
Inner and Outer Retinal Layer Thickness by Macular Region
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Thickness of the inner and outer retinal layers, in micrometers (µm), measured by SD-OCT in localized macular regions defined by the Early Treatment Diabetic Retinopathy Study (ETDRS) map.

At a single previously completed ophthalmic visit (Visit 1).
Macular Vessel Density Measured by OCT Angiography
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Vessel density measured by optical coherence tomography angiography (OCT-A) in localized macular regions and reported separately for the superficial capillary plexus, deep capillary plexus, and choriocapillaris.

At a single previously completed ophthalmic visit (Visit 1).
Inherited Retinal Dystrophy-Related Ocular Complications
Tidsramme: At a single previously completed ophthalmic visit (Visit 1).

Ocular complications documented in patients with inherited retinal dystrophies, including macular edema and cataract.

At a single previously completed ophthalmic visit (Visit 1).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Lucia Ziccardi, Professor, IRCCS Fondazione G. B. Bietti

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

10. desember 2025

Primær fullføring (Faktiske)

10. desember 2025

Studiet fullført (Antatt)

21. oktober 2036

Datoer for studieregistrering

Først innsendt

11. november 2026

Først innsendt som oppfylte QC-kriteriene

11. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

11. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • NEU 02-25
  • NEU 02-25 (N. 408/FB/25) (Annen identifikator: IRCCS Fondazione Bietti ETS)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

The individual participant data (IPD) that will be eventually shared are retinal morpho-functional evaluation of patients affected by inherited retinal dystrophies (OCT; OCT-A, mfERG, mfPhNR data), visual field, visual acuity, ocular complications related to IRDs.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .